Lv1
80 积分 2023-07-20 加入
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
2天前
已完结
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
8天前
已完结
Immune Checkpoint Inhibitor–Induced Cardiotoxicity
1个月前
已完结
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
1个月前
已完结
Diagnosis and Treatment of Metastatic Colorectal Cancer
3个月前
已完结
Colorectal cancer
3个月前
已完结
First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study
4个月前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
4个月前
已完结
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
5个月前
已完结
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
6个月前
已完结
皖公网安备34019202002308
